Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy

[1]  Y. Shibamoto,et al.  Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy , 2014, Radiation Oncology.

[2]  E. Yorke,et al.  Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT) , 2013, Radiation oncology.

[3]  Y. Shibamoto,et al.  Early response and local control of stage I non‐small‐cell lung cancer after stereotactic radiotherapy: difference by histology , 2013, Cancer science.

[4]  Y. Shibamoto,et al.  Regression curves of brain metastases after gamma knife irradiation: Difference by tumor and patient characteristics , 2012, Cancer science.

[5]  N. Kadoya,et al.  Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: a retrospective analysis , 2012, Radiation oncology.

[6]  Peter Balter,et al.  Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer , 2012, Radiation oncology.

[7]  Matthias Guckenberger,et al.  Accuracy and inter-observer variability of 3D versus 4D cone-beam CT based image-guidance in SBRT for lung tumors , 2012, Radiation oncology.

[8]  Y. Shibamoto,et al.  Stereotactic body radiotherapy using a radiobiology‐based regimen for stage I nonsmall cell lung cancer , 2012, Cancer.

[9]  M. Hiraoka,et al.  Preliminary Report of Late Recurrences, at 5 Years or More, after Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  Hiroki Shirato,et al.  Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? , 2011, International journal of radiation oncology, biology, physics.

[11]  Michael Molls,et al.  Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  Y. Shibamoto,et al.  Correlation between the serum KL-6 level and the grade of radiation pneumonitis after stereotactic body radiotherapy for stage I lung cancer or small lung metastasis. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  M. Hiraoka,et al.  Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer. , 2011, International journal of radiation oncology, biology, physics.

[14]  Steve Webb,et al.  A novel respiratory motion compensation strategy combining gated beam delivery and mean target position concept --a compromise between small safety margins and long duty cycles. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  Y. Shibamoto,et al.  Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size , 2010, Radiation Oncology.

[16]  Annette Kopp-Schneider,et al.  4D-CT-based target volume definition in stereotactic radiotherapy of lung tumours: comparison with a conventional technique using individual margins. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  Mitsuhiro Nakamura,et al.  Measurement of interfraction variations in position and size of target volumes in stereotactic body radiotherapy for lung cancer. , 2009, International journal of radiation oncology, biology, physics.

[18]  Lu Wang,et al.  Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  Yoshihiro Takai,et al.  A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  H. Shirato,et al.  Stereotactic Body Radiotherapy (SBRT, BED ≥ 100 Gy) for Operable Stage I Non-Small Cell Lung Cancer: Is SBRT Comparable to Surgery? , 2007 .

[21]  M. Hiraoka,et al.  A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer. , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[22]  Y. Shibamoto,et al.  Influence of contrast materials on dose calculation in radiotherapy planning using computed tomography for tumors at various anatomical regions: a prospective study. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  S. Senan,et al.  Is adaptive treatment planning required for stereotactic radiotherapy of stage I non-small-cell lung cancer? , 2007, International journal of radiation oncology, biology, physics.

[24]  Suresh Senan,et al.  Time trends in target volumes for stage I non-small-cell lung cancer after stereotactic radiotherapy. , 2006, International journal of radiation oncology, biology, physics.

[25]  Masahiro Hiraoka,et al.  Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. , 2005, International journal of radiation oncology, biology, physics.

[26]  Y. Shibamoto,et al.  Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  Y. Shibamoto,et al.  Reoxygenation after single irradiation in rodent tumors of different types and sizes. , 1996, International journal of radiation oncology, biology, physics.

[28]  Y. Shibamoto,et al.  Reoxygenation in the SCCVII tumor after KU-2285 sensitization plus single or fractionated irradiation. , 1994, International journal of radiation oncology, biology, physics.

[29]  Chris Williams.  Oncology , 1990, The Lancet.

[30]  Zhongxing Liao,et al.  Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  K. Ang,et al.  Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. , 1993, International journal of radiation biology.